Treating anxiety complicated by substance misuse

Advances in Psychiatric Treatment

Volumn 8, Issue 2, 2002, Pages 107-116

  Lingford Hughes, Anne ^a   Potokar, John ^a   Nutt, David ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 4 AMINOBUTYRIC ACID RECEPTOR; ALCOHOL; AMPHETAMINE; ANTICONVULSIVE AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE; BUSPIRONE; CAFFEINE; CANNABIS; CENTRAL STIMULANT AGENT; CLONIDINE; COCAINE; FLUMAZENIL; HYPNOTIC AGENT; LOFEXIDINE; METHADONE; MIRTAZAPINE; NEFAZODONE; NICOTINE; OPIATE; PSYCHEDELIC AGENT; REBOXETINE; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VENLAFAXINE;

ALCOHOL BLOOD LEVEL; ALCOHOL WITHDRAWAL; ALCOHOLISM; ANXIETY NEUROSIS; ARTICLE; COMORBIDITY; DRUG DEPENDENCE; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; FEMALE; HUMAN; MALE; NORADRENERGIC SYSTEM; OBSESSION; PERSONALITY TEST; PHOBIA; POSTTRAUMATIC STRESS DISORDER; PSYCHOLOGIC ASSESSMENT; SELF MEDICATION; SUBSTANCE ABUSE; WITHDRAWAL SYNDROME;

EID: 0036195365     PISSN: 13555146     EISSN: None     Source Type: Journal    
DOI: 10.1192/apt.8.2.107     Document Type: Article

References (44)

1. The psychobiology of anxiolytic drugs. Pharmacological treatments of anxiety
2. Panic disorder: Efficacy of current treatments
3. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers
4. Changes in anxiety among abstinent male alcoholics
5. Eye movement desensitization and reprocessing [EMDR] treatment for combat-related posttraumatic stress disorder
6. Benzodiazepine treatment of anxiety or insomnia in substance abuse patients
7. Inheritance of alcohol abuse. Cross-fostering analysis of adopted men
8. Noradrenergic function in panic disorder. Effects of intravenous clonidine pre-treatment on lactate induced panic
9. Treatment of social phobia with clonazepam and placebo
10. The relative efficacy and treatment distress of EMDR and a cognitive behavioural treatment protocol in the amelioration of post traumatic stress disorder
11. Panic attacks and alcohol withdrawal: Can subjects differentiate the symptoms?
12. Alcoholism and panic disorder: Is the comorbidity more than coincidence?
13. Behavioural and neuroendocrine responses to m-chlorophenylpiperazine in subtypes of alcoholics and in healthy comparison subjects
14. Serotonergic dysfunction, negative mood states, and response to alcohol
15. Effect of alcohol on social phobic anxiety
16. A double-blind randomized placebo-controlled trial of lofexidine in alcohol withdrawal: Lofexidine is not a useful adjunct to chlordiazepoxide
17. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States
18. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey
19. Buspirone treatment of anxious alcoholics
20. Fluoxetine treatment seems to reduce the beneficial effects of cognitive-behavioural therapy in type B alcoholics
21. Comorbidity of opiate dependence and mental disorders
22. The relation between alcohol problems and anxiety disorders
23. Subtypes of alcoholism and their role in therapy
24. Reduced levels of the GABA-benzodiazepine receptor in alcohol dependency in the absence of grey matter atrophy
25. Decreased brain GABA A-benzodiazepine receptor binding in panic disorder
26. Comorbidity of substance use disorders with mood and anxiety disorders: Results of the international consortium in psychiatric epidemiology
27. Alcohol and the brain. Pharmacological insights for psychiatrists
28. Diazepam alters brain 5HT function in man: Implications for the acute and chronic effects of benzodiazepines
29. Emotional processing during eye movement desensitization and reprocessing [EMDR] therapy of Vietnam veterans with post-traumatic stress disorder
30. Assessment of GABA A benzodiazepine receptor (GBzR) sensitivity in patients on benzodiazepines
31. Phobic anxiety syndrome complicated by drug dependence and addiction. A tretable form of drug abuse
32. Management of alcohol detoxification
33. Gender comparison in alcoholics with concurrent social phobia: Implications for alcoholism treatment
34. Concurrent alcoholism and social anxiety disorder: A first step toward developing effective treatments
35. Comorbidity of mental disorders with alcohol and other drug abuse
36. A controlled study of eye movement desensitization and reprocessing in the treatment of posttraumatic stress disordered sexual assault victims
37. Preliminary evidence of benzodiazepine subsensitivity in panic disorder
38. GABAA receptor subtypes: Dissecting out their pharmacological functions
39. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption - II
40. Placebo-controlled trial of moclobemide in social phobia
41. Managing anxiety and depression in alcohol and drug dependence
42. Pharmacotherapy of social phobia. A controlled study with moclobemide and phenelzine